wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33626095-1E3075E3-2C1C-4E2E-BA55-264C3C07D461
Q33626095-1E3075E3-2C1C-4E2E-BA55-264C3C07D461
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33626095-1E3075E3-2C1C-4E2E-BA55-264C3C07D461
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J)
P2860
Q33626095-1E3075E3-2C1C-4E2E-BA55-264C3C07D461
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33626095-1E3075E3-2C1C-4E2E-BA55-264C3C07D461
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0aed0cbbf5937d71598df7d769bdf9760c144585
P2860
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial.